Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.

Cardiol J · 2019 · PMC8086660 · PMID 30835327

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

borderline significantp = 0.052so close (0.05 < p ≤ 0.1)

Effect on short-term endpoints At 3 months there was a borderline significant reduction in serum NT-proBNP (p = 0.052) in the CoQ 10 group compared to baseline but not in the placebo group ( Table 2 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.